Micro-X Ltd (ASX: MX1) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Micro-X Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $49.83 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 559.87 million
Earnings per share -0.028
Dividend per share N/A
Year To Date Return -17.14%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Micro-X Ltd (ASX: MX1)
    Latest News

    Person pointing at an increasing blue graph which represents a rising share price.
    Healthcare Shares

    Guess which ASX medical tech share soared 37% at one point today

    We take a look at why this medical technology company soared ahead today.

    Read more »

    A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
    Broker Notes

    Top brokers name 3 ASX small cap shares to buy

    These small cap ASX shares have been named as buys...

    Read more »

    A man stands with arms crossed in front of a giant shadow of a body builder representing ASX small-cap stocks.
    Broker Notes

    Morgans picks small cap ASX shares with near-term share price catalysts

    The market looks caught in a fairly tight trading band since April as bulls and bears look to see who…

    Read more »

    MX1 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Micro-X Ltd

    Micro-X Ltd operates in the medical industry. The company operates in designs, develops, and manufactures ultra-lightweight carbon nanotube-based X-ray products for the healthcare and counter IED imaging security markets. Its product includes Nano; Rover and Mobile Backscatter Imager (MBI), Mobile Baggage Scanner (MBS), and others. Geographically, it derives a majority of revenue from Asia-Pacific and also has a presence in the United States and Europe.

    MX1 Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 May 2024 $0.09 $0.00 0.00% 1,530,456 $0.09 $0.09 $0.09
    17 May 2024 $0.09 $0.00 0.00% 548,324 $0.09 $0.09 $0.09
    16 May 2024 $0.09 $0.00 0.00% 293,393 $0.09 $0.09 $0.09
    15 May 2024 $0.09 $0.00 0.00% 16,086 $0.09 $0.09 $0.09
    14 May 2024 $0.09 $0.00 0.00% 282,837 $0.09 $0.09 $0.09
    13 May 2024 $0.09 $0.00 0.00% 102,383 $0.09 $0.09 $0.09
    10 May 2024 $0.09 $0.00 0.00% 95,787 $0.09 $0.09 $0.09
    09 May 2024 $0.09 $0.00 0.00% 6,208 $0.09 $0.09 $0.09
    08 May 2024 $0.09 $0.00 0.00% 110,000 $0.09 $0.09 $0.09
    07 May 2024 $0.09 $0.00 0.00% 359,555 $0.09 $0.09 $0.09
    06 May 2024 $0.09 $0.00 0.00% 512,789 $0.09 $0.09 $0.09
    03 May 2024 $0.09 $0.00 0.00% 1,777,874 $0.09 $0.09 $0.09
    02 May 2024 $0.09 $0.00 0.00% 500,995 $0.09 $0.09 $0.09
    01 May 2024 $0.09 $0.00 0.00% 157 $0.09 $0.09 $0.09
    30 Apr 2024 $0.09 $0.00 0.00% 1,287,712 $0.09 $0.09 $0.09
    29 Apr 2024 $0.09 $0.00 0.00% 568,455 $0.09 $0.09 $0.09
    26 Apr 2024 $0.09 $0.00 0.00% 47,879 $0.09 $0.10 $0.09
    24 Apr 2024 $0.09 $0.00 0.00% 388,738 $0.09 $0.09 $0.09
    23 Apr 2024 $0.09 $0.00 0.00% 2,305,009 $0.09 $0.09 $0.09

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    07 Jul 2023 David Knox Issued 274,424 $31,391
    Director remuneration.
    07 Jul 2023 James (Jim) McDowell Issued 201,070 $23,000
    Director remuneration. Estimated value

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Alexander Bennett Gosling Non-Executive Director Aug 2015
    Dr Gosling has been working in the field of process and product development and related research and development for 50 years. He was a founding director of Invetech and was part of the management team that led Invetech to a public listing (as Vision Systems) and then to its acquisition by Danaher Corp for $800m. He currently works in the area of technology commercialization, advising universities, mentoring start-ups and sitting on the Boards of early-stage companies.
    Mr Patrick Gerard O'Brien Non-Executive Director Aug 2015
    Mr O'Brien is also a Chairman/board member of a number of not for profit organizations and foundations. Patrick has over 30 years business experience in Australia, the UK, Europe, Asia, and the US including as a Senior Managing Director with Macquarie Group where he led teams in corporate finance (Melbourne 1996-2005) and private equity (London 2005-2009). In this latter role Patrick was responsible for Macquarie's controlling stakes in, and chaired, unlisted groups European Directories and National Grid Wireless. Prior to Macquarie, Patrick was a strategy consultant with McKinsey & Company and a lawyer with Minter Ellison. He is member of Risk Committee.
    Mr David Knox Non-Executive DirectorNon-Executive Chairman Apr 2020
    Mr Knox was Managing Director and Chief Executive Officer of Australian Naval Infrastructure, a Government Business Enterprise responsible for the delivery of naval infrastructure required to support the Commonwealth's continuous shipbuilding program, including the Osborne South Shipyard. David was previously Managing Director & Chief Executive Officer of Santos from March 2008 through until his retirement in December 2015. He is member of the Risk Committee.
    Mr James (Jim) White McDowell Non-Executive Director Jan 2021
    Mr McDowell has more than 30 years of experience in international defence and aerospace sectors and has lived and worked in the UK, the USA, Korea, Singapore, Hong Kong and Australia. Prior to this he was Chief Executive Officer of BAE Systems Australia for 10 years. Based in Adelaide, he drove an expansion program as the Group grew to become Australia's defence business. Prior to his time at BAE Systems Jim worked for 18 years at aerospace Group Bombardier Shorts in legal, commercial and marketing positions, making a contribution to that Group's growth into the USA.
    Ms Ilona Meyer Non-Executive Director Mar 2022
    Ms Meyer has over 25 years of experience as a senior executive in healthcare, agriculture and emerging technologies focusing on innovation and growth. Ilona is General Counsel and Company Secretary for Nuix Limited and prior to this role has held multiple executive roles with private and public companies, including ASX-listed companies and growth start-ups, leading business transformation initiatives, managing multiple stakeholders, as well as navigating high profile litigation and regulatory disputes. Prior to commencing her current role at Nuix, Ilona was General Counsel and Head of Legal & Compliance of the Boehringer Ingelheim Group for the Australian and New Zealand division. She is also Chair of Risk Committee.
    Mr Andrew Hartmann Non-Executive Director Dec 2022
    Mr Hartmann is the Senior Vice President and GM Imaging Solutions at Varex Imaging Corporation and has worked overseas and in global senior roles for more than 30 years. Andrew has business expertise in the field of medical imaging devices with experience working in global roles with a focus on sales, marketing and business operations. Over his career he has been responsible for building brand, market share and bottom-line gains through cost saving and efficiency improvements. Andrew has held senior global management roles at Phillips, Carestream and Siemens, after working in Australia that included building brands across the Asia Pacific region, the United States and Europe.
    Mr Kingsley Hall Company SecretaryChief Executive Officer Feb 2020
    Brian Gonzales CEO Americas & Chief Scientific Officer
    Anthony Skeats Chief Operating Officer
    Kingsley Hall Company SecretaryChief Executive Officer

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Varex Imaging Corporation 50,709,000 9.86%
    BNP Paribas Nominees Pty Ltd (DRP) 39,825,217 7.74%
    National Nominees Limited 36,399,955 7.08%
    UBS Nominees Pty Ltd 35,942,251 6.99%
    JP Morgan Nominees Australia Pty Ltd 34,802,859 6.77%
    BNP Paribas Nominees Pty Ltd (IB AU Noms Retailclient DRP) 18,430,363 3.58%
    Citicorp Nominees Pty Ltd 13,797,279 2.68%
    Mr Peter Robin Rowland 13,534,068 2.63%
    HSBC Custody Nominees (Australia) Limited 10,875,613 2.11%
    Lonsdale Nominees Pty Ltd (The Lonsdale Fund A/C) 5,904,601 1.15%
    Mr Lennie Franklin David 4,966,867 0.97%
    Harman Nominees Pty Ltd (Harmanis Investment A/C) 4,816,556 0.94%
    Bronte Investments Pty Ltd (McMahon Superannuation A/C) 4,600,279 0.89%
    Meddiscope Pty Ltd (Podesta Family A/C) 3,244,565 0.63%
    Anglesea Investments Pty Ltd (Damien O'Brien Family A/C) 2,766,379 0.54%
    Gowing Bros Limited 2,752,858 0.54%
    Vaben Pty Ltd (The Vaben Superannuation A/C) 2,565,931 0.50%
    Dr Russell Kay Hancock 2,500,000 0.49%
    Kanat Nominees Pty Ltd (Aaron Kanat ML A/C) 2,420,828 0.47%
    Charli Jordan Pty Ltd (Molloy Settlement A/C) 2,400,000 0.47%